Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.

ibdwatch

Related Articles Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development. Lancet Gastroenterol Hepatol. 2019 Feb 11;: Authors: King JA, Underwood FE, Panaccione N, Quan J, Windsor JW, Kotze PG, Ng SC, Ghosh S, Lakatos PL, Jess T, Panaccione R, Seow CH, Ben-Horin S, Burisch J, Colombel JF, Loftus EV, Gearry R, Halfvarson J, Kaplan GG Abstract BACKGROUND: Hospitalisation rates for inflammatory bowel disease (IBD) vary across the world. We aimed to…

Read More

Health Care Transition Outcomes in Inflammatory Bowel Disease: a Multinational Delphi Study.

ibdwatch

Related Articles Health Care Transition Outcomes in Inflammatory Bowel Disease: a Multinational Delphi Study. J Crohns Colitis. 2019 Feb 14;: Authors: Brink GVD, Gaalen MACV, de Ridder L, van der Woude CJ, Escher JC Abstract BACKGROUND: Transition programs are designed to prepare adolescent Inflammatory Bowel Disease (IBD) patients for transfer to adult care. It is still unclear which outcome parameters define “successful transition”. Therefore, this study aimed to identify outcomes important for success of transition in IBD. METHODS: A multinational Delphi study in patients, IBD-nurses and paediatric and adult gastroenterologists…

Read More

Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.

ibdwatch

Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort. J Crohns Colitis. 2019 Feb 14;: Authors: Plevris N, Chuah CS, Allen RM, Arnott ID, Brennan PN, Chaudhary S, Churchhouse AMD, Din S, Donoghue E, Gaya DR, Groome M, Jafferbhoy HM, Jenkinson PW, Lam WL, Lyons M, Macdonald JC, MacMaster M, Mowat C, Naismith GD, Potts LF, Saffouri E, Seenan JP, Sengupta A, Shasi P, Sutherland DI, Todd JA, Veryan J, Watson AJM, Watts DA, Jones GR, Lees CW Abstract INTRODUCTION: Vedolizumab is…

Read More

A Validated Score Assessing the Risk for an Intra-Abdominal Abscess in Patients with Crohn’s Disease Presenting at the Emergency Department.

ibdwatch

A Validated Score Assessing the Risk for an Intra-Abdominal Abscess in Patients with Crohn’s Disease Presenting at the Emergency Department. J Crohns Colitis. 2019 Feb 14;: Authors: Khoury T, Daher S, Massarwa M, Hakimian D, Benson AA, Viener E, Farah R, Mari A, Hazou W, Kadah A, Sbeit W, Mahamid M, Israeli E Abstract BACKGROUND AND AIMS: A majority of acutely-ill Crohn’s disease (CD) patients who present to Emergency Department (ED) will undergo an abdominal CT to rule out disease complications. We aimed to generate a simple non-invasive scoring model…

Read More

Placing Value on Telemedicine for Inflammatory Bowel Disease.

ibdwatch

Placing Value on Telemedicine for Inflammatory Bowel Disease. Am J Gastroenterol. 2019 Jan 30;: Authors: Siegel CA Abstract Telemedicine can take a number of forms. A popular approach is the use of telemonitoring, which takes advantage of available technology to follow patients remotely. Cross and colleagues present the results of a well-done randomized controlled trial to assess the impact of a telemonitoring program for patients with inflammatory bowel disease. They did not show a difference in disease activity, but this study leads us to question whether we know the appropriate…

Read More

Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.

ibdwatch

Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study. Inflamm Bowel Dis. 2018 Aug 16;24(9):2015-2026 Authors: Nissen LHC, Derikx LAAP, Jacobs AME, van Herpen CM, Kievit W, Verhoeven R, van den Broek E, Bekers E, van den Heuvel T, Pierik M, Rahamat-Langendoen J, Takes RP, Melchers WJG, Nagtegaal ID, Hoentjen F, Dutch Initiative on Crohn and Colitis (ICC) , Dutch Head and Neck Society, PALGA group, IBD/HNC group Abstract Background: Immunosuppressed inflammatory bowel disease (IBD) patients are at increased risk to…

Read More

Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016.

ibdwatch

Related Articles Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016. Dig Dis Sci. 2019 Feb 12;: Authors: Xu F, Dahlhamer JM, Terlizzi EP, Wheaton AG, Croft JB Abstract BACKGROUND: Previous reports suggest that adults with inflammatory bowel disease (IBD) receive suboptimal preventive care. AIMS: The population-based study compared the receipt of these services by US adults with and without IBD. METHODS: Adults aged ≥ 18 years with IBD (1.2%) and without IBD were identified from the 2015 and 2016 National Health Interview Survey (n = 66,610). Age-standardized prevalence of…

Read More

Personalized Inflammatory Bowel Disease Care Reduced Hospitalizations.

ibdwatch

Related Articles Personalized Inflammatory Bowel Disease Care Reduced Hospitalizations. Dig Dis Sci. 2019 Feb 12;: Authors: Liu JJ, Rosson TB, Xie JJ, Harris ZP, McBride RG, Siegel E, Hagedorn C Abstract BACKGROUND AND AIMS: IBD patients with inadequately treated disease often relapse and require hospitalizations for further management. The purpose of this practice review was to determine whether personalized IBD care improved patient outcomes as measured by IBD-related hospitalizations. METHODS: A dedicated IBD clinic was created for personalized patient care in a tertiary veterans health care center in 2014. In…

Read More
<< Go Back